AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Fondaparinux plus compression prevents VTE.(Gynecologic Surgery)

OB GYN News

| May 01, 2006 | Brunk, Doug | COPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

PALM SPRINGS, CALIF. -- Once-daily fondaparinux 2.5 mg for 5-7 days combined with pneumatic compression was significantly more effective than intermittent pneumatic compression alone for preventing venous thrombosis after elective major abdominal surgery, Dr. Joseph A. Caprini reported at the annual meeting of the Society of Gynecologic Oncologists.

That marks the chief conclusion of the APOLLO study, a multicenter, randomized, double-blind, placebo-controlled trial designed to compare the efficacy of fondaparinux and intermittent pneumatic compression (IPC) vs. IPC alone for preventing venous thromboembolic events (VTE) after major abdominal surgery. The study is the largest of its kind to date.

"This trial has taught us two really important things," said Dr. Caprini, professor of surgery at Northwestern University, Chicago. "In patients who aren't at much risk, don't use very much [low-molecular-weight heparin]. In patients who have really high risk, use the modality that has been shown to give the most effective reduction in venous thromboembolism."

He and his associates randomized 1,309 patients, who were older than age 40 years and underwent major abdominal surgery, to receive either fondaparinux (2.5 mg) or a placebo shot of saline subcutaneously once a day starting 6-8 hours after surgery and then once daily for 5-7 days. Every patient in the study received IPC devices per each hospital's protocol. These included calf-high devices and thigh-high devices. Stockings were also used, but foot pumps were not allowed.

Of 1,309 patients, only 842 (64%) were evaluable. About half of the patients were women, the average age was 60 years, and most were white. "The procedures were mostly gastrointestinal procedures, which included laparoscopic cholecystectomy," Dr. Caprini said. Nearly half (40%) underwent cancer surgery, 18% underwent urologic surgery, and 9% underwent gynecologic surgery.

The majority of patients were at moderate risk of VTE, based on guidelines from the American ...

Related articles from newspapers, magazines, journals, and more
Fondaparinux cut event, bleeding risk in ACS.(Cardiovascular Medicine)(acute...
Magazine article from: Internal Medicine News Jancin, Bruce December 1, 2006 700+ words
...with enoxaparin alone, 5.9% with fondaparinux alone, 4.3% with enoxaparin plus UFH, and comparably low with fondaparinux plus UFH. "These data suggest that unfractionated heparin is a good anticoagulant for PCI and probably better than using enoxaparin...
For more facts and information, see all results

Source: HighBeam Research, Fondaparinux plus compression prevents VTE.(Gynecologic Surgery)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA